News AI, genomics expert leaves Pathos AI, will advise Pfizer Pfizer is creating the role of AI Scholar for computational biologist Eric Schadt, who is leaving Pathos AI to start a new stealth venture.
News Bioptimus, Cancer Research Horizons partner on AI-powered pr... Bioptimus, a global AI biotech company, has announced a partnership with Cancer Research Horizons, the innovation engine of Cancer Research UK.
Digital Australia, AI, and Autolomous pharmaphorum spoke with Alexander Seyf, CEO of Autolomous, about the future of AI in Australian biotech.
Sales & Marketing Why trust is becoming pharma’s most important visibility met... Any gap between an AI-generated answer and a product’s approved profile carries consequences for prescribing decisions and patient safety.
News Genpact finds $18tn in trapped AI value Genpact and analyst firm HFS Research recently published a new global study identifying four enterprise debts.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.